GoldenGolden
Advanced Search
Mediphase Venture Partners

Mediphase Venture Partners

A Newton-based venture capital firm that invests in health care and life sciences companies

Edit ID  13413119 

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 8 Feb, 2020
Edits made to:
Description (+91 characters)
Article (+805/-549 characters)
Topic thumbnail

Mediphase Venture Partners

A Newton-based venture capital firm that invests in health care and life sciences companies

Article

Mediphase Venture Partners is a venture capital firm founded in 1999. The firm is based in Newton, Massachusetts, United States. Mediphase Venture Partners prefers to fund companies at the early stage of development. It invests in companies operating in the life science and healthcare sectors. These include companies developing products and services in the following field: diagnostic equipment, pharmaceuticals, and biotechnology. As of April 2015, Mediphase Venture Partners has invested in 45 companies and sold off its stakes in 26 companies.

Mediphase Venture Partners is a venture capital firm in Newton that prefers to invest in life sciences and healthcare companies with a focus on biopharmaceutical technology and life sciences information. Founded in 1999 by Lawrence Miller and Paul Howard in Newton, Massachusetts, the firm invests in early stage ventures, late stage ventures, and private equity rounds. The notable investment portfolio of Mediphase Venture Partners includes Relypsa,Tetraphase Pharmaceuticals, Wellpartner, and Concert Pharmaceuticals. As of February 2020, Mediphase Venture Partners has made 21 investments. Their most recent investment was on Aug 14, 2012, when Relypsa raised $80M. Mediphase Venture Partners has had seven exits, the most notable of which include Relypsa, Concert Pharmaceuticals, and PatientKeeper.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.